The pharma industry’s reputation has continued to slide — and it’s mostly due to the persistent issue of high drug costs, according to a report released by research firm PatientView this week.
Hosted on MSN
Adam Silver defends NBA ratings decline
The NBA’s ratings discourse this season has arguably generated more headlines than the actual play on the court. That’s a bit of hyperbole, but the sentiment is true. This year, more than usual, the ...
Target faced significant sales and reputation declines after rolling back DEI policies and controversial Pride Month displays, leading to widespread boycotts and a 30% stock drop. However, RepTrak ...
Forbes contributors publish independent expert analyses and insights. Lindsay Kohler is a behavioral scientist and future of work expert. In a time when trust in business is declining — Edelman ...
Paul Finebaum believes Bill Belichick’s reputation has shifted dramatically since taking over at North Carolina, noting how even broadcasters have begun defending his every decision amid the Tar Heels ...
Companies that maintained their commitments to diversity, equity and inclusion saw reputation scores rise in this year's Axios Harris Poll 100 reputation rankings. Why it matters: Unclear corporate ...
Yesterday, the startling news came that after more than 45 years of Buss family ownership, the Los Angeles Lakers would change hands at an eye-popping valuation of $10 billion. How much incoming owner ...
The NBA’s ratings discourse this season has arguably generated more headlines than the actual play on the court. That’s a bit of hyperbole, but the sentiment is true. This year, more than usual, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results